Developer docs
API playgroundTry for free, no card

Search company profiles

iPlato Healthcare

Full company profile

uuid0005cv1

Namestring
iPlato Healthcare
Legal namestring
iPLATO Ltd
Websiteurl
iplato.com
Company typeenum
Private
Founded yearint
1999
Descriptiontext

iPLATO Healthcare (iPLATO Ltd) is a UK-based health technology company, headquartered in Hammersmith and founded in 1999, that develops and operates myGP, a patient engagement platform serving UK primary care and population health. The company operates a single unified technology platform that powers a modular product portfolio organised into three practice areas: Primary Care (the Connect+ bundle comprising Connect, Patient Questionnaires, Selfbook, Toolbar, Triage, and the Friends and Family Test), Population Health (Engagement Hub, Data Science, and Digital Front Door), and Hospital at Home (Digital Checklist: SACT and GDm-Health for systemic anti-cancer therapy and gestational diabetes remote monitoring respectively). On top of this platform iPLATO packages vertical care-pathway solutions for Respiratory, Cardio, Cancer, Mental Health, and Research (IRN).

The company's customer base is concentrated within the UK NHS: iPLATO reports deployment at over 50% of NHS Payers, 2,518 GP surgeries, and a 34m patient network, with 2.8m health-conscious patients using the myGP consumer-facing app. The GTM motion combines enterprise field sales targeting NHS Payers, CCGs, and GP practices (initiated through an "Exploration Call" CTA, indicating quote-based, contract-negotiated enterprise pricing) with a direct-to-consumer layer via the myGP app. Revenue is generated primarily through recurring SaaS subscriptions sold to NHS and primary care providers, with the myGP app functioning as an engagement channel into the B2B platform.

iPLATO is part of the Huma Therapeutics group, evidenced by the iPLATO website linking to the Huma Therapeutics Carbon Reduction Plan, co-branded Hospital at Home products, and the December 2024 launch of Huma Intelligence & Selfbook that integrates Huma's capabilities into the iPLATO platform. Leadership comprises Tobias Alpsten as Chief Executive Officer and Namrata Sarmah in a Chief Product / CXO role. The company is privately held (no public ticker disclosed) with disclosed funding of approximately $7.7m across rounds led by SBRI Healthcare (2016, 2023) and Caple BV (2020), and operates UK-based teams in the UK and Czech Republic with 51–100 total employees.

Short descriptiontext

iPLATO Healthcare is a UK-based health technology company operating the myGP patient engagement platform, serving NHS Payers, GP surgeries, and 2.8m patients through enterprise SaaS subscriptions for primary care, population health, and Hospital at Home workflows.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersHammersmith, United Kingdom
HQ citystring
Hammersmith
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
patient engagement software, healthcare communication platform, remote patient monitoring, population health analytics, NHS digital primary care
Industry3 codes
1Patient Engagement, Education & Messaging Platforms (portal/CRM integrated)
CodeHLALABAJPrimaryYes
2Care Navigation, Referral & Digital Front Door Platforms
CodeHLALABAHPrimaryNo
3Chronic Condition Virtual Care & Disease Management (Payer-Sponsored)
CodeHLALACAEPrimaryNo
NAICS code1 code
  • Home Health Care Services621610
SIC code1 code
  • Services-Misc Health & Allied Services, Nec8090
Product category
Healthcare Patient Engagement Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Enterprise SaaS to NHS and primary care providers
TypeSubscription Recurring
Description

Recurring software contracts sold to NHS Payers, CCGs, and GP surgeries for Connect+, Engagement Hub, Data Science, Digital Front Door, and Hospital-at-Home products. Buyer base is the UK NHS and primary care ecosystem, with >50% of NHS Payers as customers.

iplato.com:443
2Consumer-side engagement via myGP app
TypeFreemium
Description

Patient-facing myGP app (2.8m health-conscious patients) acts as an engagement surface for NHS/GP customers and a potential adjacent monetisation channel; primary monetisation is on the B2B side via NHS subscriptions.

iplato.com:443
Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1myGP
Description

Consumer-facing mobile app branded separately from the iPLATO corporate name; 2.8m health-conscious patients reported as users.

iplato.com:443
+3 more records
Core offering1 text field

iPlato Healthcare develops and sells the iPLATO patient engagement platform, used by NHS Payers, CCGs and GP surgeries to communicate with patients, manage primary care workflows, run population health programmes and deliver Hospital at Home remote monitoring. Its flagship products include the Connect+ primary care suite, the myGP consumer app, population health modules (Engagement Hub, Data Science, Digital Front Door) and condition-specific tools such as GDm-Health and the SACT digital checklist.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

iPlato offers a single underlying technology platform — the iPLATO platform — that powers a portfolio of modular products and solutions organised into three practice areas: Primary Care (built around the Connect+ bundle, with sub-modules Connect, Patient Questionnaires, Selfbook, Toolbar, Triage, and Friends and Family Test), Population Health (Engagement Hub, Data Science, and Digital front door), and Hospital at Home (Digital checklist: SACT and GDm-Health). On top of this platform, iPlato packages vertical solutions for Respiratory, Cardio, Research (IRN), Cancer, and Mental Health, alongside the patient-facing myGP app. Together with innovation partners, the platform transforms fragmented care routes into streamlined digital-first patient pathways used by over 50% of NHS Payers, 2,518 GP surgeries, and a 34m patient network.

Product and service10 records
1iPLATO Platform
CategoryPatient engagement platform
Description

Core unified technology platform from iPlato Healthcare that underpins primary care patient engagement, population health management and Hospital at Home remote monitoring. Used by NHS Payers, CCGs, GP surgeries and secondary care providers.

2Connect+
CategoryPrimary care patient engagement
Description

Primary care patient engagement suite that combines appointment reminders, patient questionnaires, self-booking, toolbar workflows, online triage and Friends and Family Test collection into a single product for GP surgeries and PCNs.

3Engagement Hub
CategoryPopulation health management
Description

Population Health module that delivers targeted, multi-channel patient engagement campaigns at scale for NHS Payers, CCGs and GP surgeries to manage defined patient cohorts.

4Data Science
CategoryPopulation health analytics
Description

Population Health analytics product that combines iPlato datasets with NHS data sources to deliver population health insight, risk stratification and outcomes analysis for NHS organisations.

5Digital front door
CategoryPopulation health access
Description

Population Health solution that gives patients a single digital entry point into NHS services via online triage, signposting and self-service pathways.

6GDm-Health
CategoryHospital at Home / remote monitoring
Description

Hospital at Home remote monitoring product for gestational diabetes, enabling expectant mothers to record and share blood glucose readings with their clinical team outside of hospital.

7SACT digital checklist
CategoryHospital at Home / oncology workflows
Description

Hospital at Home digital checklist product supporting systemic anti-cancer therapy (SACT) workflows for oncology teams and their patients.

8myGP
CategoryConsumer patient app
Description

Consumer-facing mobile app used by 2.8 million health-conscious patients to manage appointments, repeat prescriptions, NHS login access and other primary care interactions.

9Respiratory solution
CategoryCondition-specific solution
Description

Condition-specific digital care pathway for respiratory patients, designed for NHS primary and secondary care teams managing long-term respiratory conditions.

10Cardio solution
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK primary care patient communication and messaging platform used by GP surgeries for appointment booking, questionnaires and two-way SMS — directly competing with iPLATO's Connect+ suite in the same NHS primary care buying motion.

TypeDirect peer
Description

NHS online consultation and triage platform for GP practices; now part of the Huma Therapeutics group alongside iPLATO, so directly comparable as a primary care digital front-door and triage peer.

TypeBroad incumbent
Description

Major UK provider of clinical software (EMIS Web) to GP practices, with adjacent patient engagement and population health capabilities — overlapping with iPLATO's primary care footprint across thousands of NHS GP surgeries.

TypeBroad incumbent
Description

UK primary and secondary care EPR and patient-facing software vendor (SystmOne), serving a large share of NHS GP surgeries — a broad incumbent competitor to iPLATO at the practice-IT layer.

TypeEmerging player
Description

UK-based virtual ward and remote patient monitoring provider with NHS contracts, directly comparable to iPLATO's Hospital at Home products (GDm-Health, SACT) in delivering care outside hospital settings.

TypeBroad incumbent
Description

Parent group of iPLATO and operator of Huma Workspace for health systems, combining digital-first care pathways, remote monitoring and hospital-at-home capabilities that subsume iPLATO's product set within a broader digital health platform.

TypeBroad incumbent
Description

UK-originated digital health and GP consultation platform, historically competing with iPLATO-adjacent primary care services through NHS partnerships and direct-to-consumer video consultations.

TypeRegional player
Description

UK digital GP consultation service, overlapping with iPLATO's primary care value proposition around patient access to GPs, though focused on video consultations rather than practice-level engagement tooling.

TypeEmerging player
Description

Conversational AI triage and patient engagement platform with NHS deployments, comparable to iPLATO's Triage, Digital Front Door and Selfbook capabilities for routing patients into appropriate services.

TypeRegional player
Description

European digital GP and patient engagement provider (Kry/Livi) operating in the UK NHS via GP federations, overlapping with iPLATO's primary care patient engagement and access proposition.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

iPlato Healthcare

Healthcare Patient Engagement Softwareiplato.com

iPLATO Healthcare is a UK-based health technology company operating the myGP patient engagement platform, serving NHS Payers, GP surgeries, and 2.8m patients through enterprise SaaS subscriptions for primary care, population health, and Hospital at Home workflows.

What iPlato Healthcare does

iPLATO Healthcare (iPLATO Ltd) is a UK-based health technology company, headquartered in Hammersmith and founded in 1999, that develops and operates myGP, a patient engagement platform serving UK primary care and population health. The company operates a single unified technology platform that powers a modular product portfolio organised into three practice areas: Primary Care (the Connect+ bundle comprising Connect, Patient Questionnaires, Selfbook, Toolbar, Triage, and the Friends and Family Test), Population Health (Engagement Hub, Data Science, and Digital Front Door), and Hospital at Home (Digital Checklist: SACT and GDm-Health for systemic anti-cancer therapy and gestational diabetes remote monitoring respectively). On top of this platform iPLATO packages vertical care-pathway solutions for Respiratory, Cardio, Cancer, Mental Health, and Research (IRN).

The company's customer base is concentrated within the UK NHS: iPLATO reports deployment at over 50% of NHS Payers, 2,518 GP surgeries, and a 34m patient network, with 2.8m health-conscious patients using the myGP consumer-facing app. The GTM motion combines enterprise field sales targeting NHS Payers, CCGs, and GP practices (initiated through an "Exploration Call" CTA, indicating quote-based, contract-negotiated enterprise pricing) with a direct-to-consumer layer via the myGP app. Revenue is generated primarily through recurring SaaS subscriptions sold to NHS and primary care providers, with the myGP app functioning as an engagement channel into the B2B platform.

iPLATO is part of the Huma Therapeutics group, evidenced by the iPLATO website linking to the Huma Therapeutics Carbon Reduction Plan, co-branded Hospital at Home products, and the December 2024 launch of Huma Intelligence & Selfbook that integrates Huma's capabilities into the iPLATO platform. Leadership comprises Tobias Alpsten as Chief Executive Officer and Namrata Sarmah in a Chief Product / CXO role. The company is privately held (no public ticker disclosed) with disclosed funding of approximately $7.7m across rounds led by SBRI Healthcare (2016, 2023) and Caple BV (2020), and operates UK-based teams in the UK and Czech Republic with 51–100 total employees.

iPlato Healthcare firmographics

Firmographics
Name
iPlato Healthcare
Legal name
iPLATO Ltd
Website
https://iplato.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
51–100 employees
Short description
iPLATO Healthcare is a UK-based health technology company operating the myGP patient engagement platform, serving NHS Payers, GP surgeries, and 2.8m patients through enterprise SaaS subscriptions for primary care, population health, and Hospital at Home workflows.
Ownership category
akta.pro rank

iPlato Healthcare industry classification

Industry
Product category
Healthcare Patient Engagement Software
NAICS
Home Health Care Services (621610)
SIC
Services-Misc Health & Allied Services, Nec (8090)
akta.pro primary industry
Patient Engagement, Education & Messaging Platforms (portal/CRM integrated) (HLALABAJ)
akta.pro secondary industries
Care Navigation, Referral & Digital Front Door Platforms (HLALABAH), Chronic Condition Virtual Care & Disease Management (Payer-Sponsored) (HLALACAE)

Keywords

  • Patient engagement software
  • Healthcare communication platform
  • Remote patient monitoring
  • Population health analytics
  • NHS digital primary care

Where iPlato Healthcare is headquartered

Location

Headquarters

HQ city
Hammersmith
HQ country
United Kingdom
HQ region
Europe

Markets served

iPlato Healthcare business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Enterprise SaaS to NHS and primary care providers: Recurring software contracts sold to NHS Payers, CCGs, and GP surgeries for Connect+, Engagement Hub, Data Science, Digital Front Door, and Hospital-at-Home products. Buyer base is the UK NHS and primary care ecosystem, with >50% of NHS Payers as customers.
  2. Consumer-side engagement via myGP app: Patient-facing myGP app (2.8m health-conscious patients) acts as an engagement surface for NHS/GP customers and a potential adjacent monetisation channel; primary monetisation is on the B2B side via NHS subscriptions.

Go-to-market motion2 records

iPlato Healthcare product offering

Product offering

Core offering

iPlato Healthcare develops and sells the iPLATO patient engagement platform, used by NHS Payers, CCGs and GP surgeries to communicate with patients, manage primary care workflows, run population health programmes and deliver Hospital at Home remote monitoring. Its flagship products include the Connect+ primary care suite, the myGP consumer app, population health modules (Engagement Hub, Data Science, Digital Front Door) and condition-specific tools such as GDm-Health and the SACT digital checklist.

Product overview

iPlato offers a single underlying technology platform — the iPLATO platform — that powers a portfolio of modular products and solutions organised into three practice areas: Primary Care (built around the Connect+ bundle, with sub-modules Connect, Patient Questionnaires, Selfbook, Toolbar, Triage, and Friends and Family Test), Population Health (Engagement Hub, Data Science, and Digital front door), and Hospital at Home (Digital checklist: SACT and GDm-Health). On top of this platform, iPlato packages vertical solutions for Respiratory, Cardio, Research (IRN), Cancer, and Mental Health, alongside the patient-facing myGP app. Together with innovation partners, the platform transforms fragmented care routes into streamlined digital-first patient pathways used by over 50% of NHS Payers, 2,518 GP surgeries, and a 34m patient network.

Differentiator

Problem solved

Functional benefit

Brands

  • myGP: Consumer-facing mobile app branded separately from the iPLATO corporate name; 2.8m health-conscious patients reported as users.
  • Connect+
  • Engagement Hub
  • GDm-Health

Products and services

  • iPLATO Platform Core unified technology platform from iPlato Healthcare that underpins primary care patient engagement, population health management and Hospital at Home remote monitoring. Used by NHS Payers, CCGs, GP surgeries and secondary care providers.
  • Connect+ Primary care patient engagement suite that combines appointment reminders, patient questionnaires, self-booking, toolbar workflows, online triage and Friends and Family Test collection into a single product for GP surgeries and PCNs.
  • Engagement Hub Population Health module that delivers targeted, multi-channel patient engagement campaigns at scale for NHS Payers, CCGs and GP surgeries to manage defined patient cohorts.
  • Data Science Population Health analytics product that combines iPlato datasets with NHS data sources to deliver population health insight, risk stratification and outcomes analysis for NHS organisations.
  • Digital front door Population Health solution that gives patients a single digital entry point into NHS services via online triage, signposting and self-service pathways.
  • GDm-Health Hospital at Home remote monitoring product for gestational diabetes, enabling expectant mothers to record and share blood glucose readings with their clinical team outside of hospital.
  • SACT digital checklist Hospital at Home digital checklist product supporting systemic anti-cancer therapy (SACT) workflows for oncology teams and their patients.
  • myGP Consumer-facing mobile app used by 2.8 million health-conscious patients to manage appointments, repeat prescriptions, NHS login access and other primary care interactions.
  • Respiratory solution Condition-specific digital care pathway for respiratory patients, designed for NHS primary and secondary care teams managing long-term respiratory conditions.
  • Cardio solution

Companies that use iPlato Healthcare

Customer profile

Ideal customer profiles3 records

iPlato Healthcare technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

iPlato Healthcare partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights6 records

iPlato Healthcare competitors and assessment

Company assessment

Direct peers

  • accuRx: UK primary care patient communication and messaging platform used by GP surgeries for appointment booking, questionnaires and two-way SMS — directly competing with iPLATO's Connect+ suite in the same NHS primary care buying motion.
  • eConsult: NHS online consultation and triage platform for GP practices; now part of the Huma Therapeutics group alongside iPLATO, so directly comparable as a primary care digital front-door and triage peer.

Broad incumbents

  • EMIS Group: Major UK provider of clinical software (EMIS Web) to GP practices, with adjacent patient engagement and population health capabilities — overlapping with iPLATO's primary care footprint across thousands of NHS GP surgeries.
  • TPP (The Phoenix Partnership): UK primary and secondary care EPR and patient-facing software vendor (SystmOne), serving a large share of NHS GP surgeries — a broad incumbent competitor to iPLATO at the practice-IT layer.
  • Huma Therapeutics: Parent group of iPLATO and operator of Huma Workspace for health systems, combining digital-first care pathways, remote monitoring and hospital-at-home capabilities that subsume iPLATO's product set within a broader digital health platform.
  • Babylon Health (eMed): UK-originated digital health and GP consultation platform, historically competing with iPLATO-adjacent primary care services through NHS partnerships and direct-to-consumer video consultations.

Emerging players

  • Doccla: UK-based virtual ward and remote patient monitoring provider with NHS contracts, directly comparable to iPLATO's Hospital at Home products (GDm-Health, SACT) in delivering care outside hospital settings.
  • Sensely: Conversational AI triage and patient engagement platform with NHS deployments, comparable to iPLATO's Triage, Digital Front Door and Selfbook capabilities for routing patients into appropriate services.

Regional players

  • Push Doctor: UK digital GP consultation service, overlapping with iPLATO's primary care value proposition around patient access to GPs, though focused on video consultations rather than practice-level engagement tooling.
  • Livi (by Kry): European digital GP and patient engagement provider (Kry/Livi) operating in the UK NHS via GP federations, overlapping with iPLATO's primary care patient engagement and access proposition.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

iPlato Healthcare social profiles

Digital presence

iPlato Healthcare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

iPlato Healthcare leadership team

Management profile

Number of profiles

Profiles2 records

iPlato Healthcare funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

iPlato Healthcare M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iPlato Healthcare

What does iPlato Healthcare do?

iPlato Healthcare develops and sells the iPLATO patient engagement platform, used by NHS Payers, CCGs and GP surgeries to communicate with patients, manage primary care workflows, run population health programmes and deliver Hospital at Home remote monitoring. Its flagship products include the Connect+ primary care suite, the myGP consumer app, population health modules (Engagement Hub, Data Science, Digital Front Door) and condition-specific tools such as GDm-Health and the SACT digital checklist.

Is iPlato Healthcare a public or private company?

iPlato Healthcare is a private company. It is classified as corporate owned and is currently operating.

When was iPlato Healthcare founded?

iPlato Healthcare was founded in 1999. It employs 51 to 100 people.

Where is iPlato Healthcare based?

iPlato Healthcare is headquartered in Hammersmith, United Kingdom, in the Europe region.

How does iPlato Healthcare make money?

Two revenue lines are on record. Enterprise SaaS to NHS and primary care providers are the primary driver. The others are consumer-side engagement via myGP app.

Who are iPlato Healthcare's main competitors?

Direct peers on record are accuRx and eConsult. Broad incumbents are EMIS Group, TPP (The Phoenix Partnership), Huma Therapeutics and Babylon Health (eMed). Emerging players are Doccla and Sensely. Regional players are Push Doctor and Livi (by Kry).

Does iPlato Healthcare have an API?

No public API is recorded for iPlato Healthcare.

What industry is iPlato Healthcare in?

iPlato Healthcare's product category is Healthcare Patient Engagement Software. Its primary akta.pro industry code is HLALABAJ, Patient Engagement, Education & Messaging Platforms (portal/CRM integrated), with a secondary code of HLALABAH, Care Navigation, Referral & Digital Front Door Platforms. Its NAICS code is 621610 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals